Literature DB >> 16767402

Correlation of grading and duration of periventricular echodensities with neurodevelopmental outcome in preterm infants.

Bernhard Resch1, Andrea Jammernegg, Eva Perl, Michael Riccabona, Ute Maurer, Wilhelm D Müller.   

Abstract

BACKGROUND: Transient periventricular echodensities (PVE) in preterm infants affect neurodevelopmental outcome.
OBJECTIVE: To correlate the duration and grading of PVE with neurodevelopmental outcome.
MATERIALS AND METHODS: A retrospective, single-centre cohort study of infants with PVE diagnosed by ultrasonography from 1995 to 2000 with blinded grading and recognition of duration of PVE.
RESULTS: A total of 72 infants (median gestational age 32 weeks, median birth weight 1,668 g) were diagnosed as having PVE. Minor neurological abnormalities were diagnosed in seven (10%), cerebral palsy in six (8%), developmental delay in seven (10%), and mild mental retardation in two (3%) of the infants. Differences regarding adverse outcome were not significant between infants with severity grade 1 compared to severity grade 2 (16% and 22%, respectively). There was a significant increase in adverse neurodevelopmental outcome with increasing duration of PVE. Of 33 infants with duration of PVE<7 days, 1 (3%) had an adverse neurodevelopmental outcome, compared to 6 (24%) of 25 infants with a duration of PVE of 7-14 days, and 6 (43%) of 14 infants with a duration of PVE>14 days (P<0.002, RR 7.920, 95% CI 1.017-61.661; P<0.001, RR 14.143, 95% CI 1.871-106.895, respectively).
CONCLUSION: The duration, but not the grading, of transient PVE was significantly correlated with neurodevelopmental outcome.

Entities:  

Mesh:

Year:  2006        PMID: 16767402     DOI: 10.1007/s00247-006-0178-2

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  24 in total

1.  Transient periventricular echodensities and developmental outcome in preterm infants.

Authors:  F F Lai; K Y Tsou
Journal:  Pediatr Neurol       Date:  1999-11       Impact factor: 3.372

2.  Neurodevelopmental outcome of transient neonatal intracerebral echodensities.

Authors:  R E Appleton; R E Lee; E N Hey
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

3.  Follow up studies during the first five years of life: a pervasive assessment of neurological function.

Authors:  C Amiel-Tison; A Stewart
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

Review 4.  Brain injury in the premature infant. Neuropathology, clinical aspects, pathogenesis, and prevention.

Authors:  J J Volpe
Journal:  Clin Perinatol       Date:  1997-09       Impact factor: 3.430

5.  Outcome of transient periventricular echodensities in preterm infants.

Authors:  J Ringelberg; M van de Bor
Journal:  Neuropediatrics       Date:  1993-10       Impact factor: 1.947

Review 6.  The spectrum of leukomalacia using cranial ultrasound.

Authors:  L S de Vries; P Eken; L M Dubowitz
Journal:  Behav Brain Res       Date:  1992-07-31       Impact factor: 3.332

7.  Intraventricular haemorrhage and periventricular leucomalacia: ultrasound and autopsy correlation.

Authors:  J Q Trounce; D Fagan; M I Levene
Journal:  Arch Dis Child       Date:  1986-12       Impact factor: 3.791

8.  Echogenic periventricular halo: normal sonographic finding or neonatal cerebral hemorrhage.

Authors:  E G Grant; D Schellinger; J D Richardson; M L Coffey; J G Smirniotopoulous
Journal:  AJR Am J Roentgenol       Date:  1983-04       Impact factor: 3.959

9.  Preterm twin gestation and cystic periventricular leucomalacia.

Authors:  B Resch; A Jammernegg; E Vollaard; U Maurer; W D Mueller; B Pertl
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-07       Impact factor: 5.747

10.  [Transient periventricular echodensities (TPE) in preterm infants under 1500 gramms: an analysis of the outcome of the last 10 years].

Authors:  C Kreuzer; B Urlesberger; U Maurer; W Müller
Journal:  Klin Padiatr       Date:  2003 Sep-Oct       Impact factor: 1.349

View more
  8 in total

1.  Periventricular echodensities in preterm infants.

Authors:  John Leonidas
Journal:  Pediatr Radiol       Date:  2006-09-29

2.  Isolated mild white matter signal changes in preterm infants: a regional approach for comparison of cranial ultrasound and MRI findings.

Authors:  M Weinstein; D Ben Bashat; V Gross-Tsur; Y Leitner; I Berger; R Marom; R Geva; S Uliel; L Ben-Sira
Journal:  J Perinatol       Date:  2014-03-20       Impact factor: 2.521

3.  Predictability of cerebral palsy and its characteristics through neonatal cranial ultrasound in a high-risk NICU population.

Authors:  Eveline Himpens; Ann Oostra; Inge Franki; Georges Van Maele; Piet Vanhaesebrouck; Christine Van den Broeck
Journal:  Eur J Pediatr       Date:  2010-05-16       Impact factor: 3.183

4.  Cinegraphic versus Combined Static and Cinegraphic Imaging for Initial Cranial Ultrasound Screening in Premature Infants.

Authors:  M Cody O'Dell; Christopher Cassady; Gregory Logsdon; Laura Varich
Journal:  Pediatr Radiol       Date:  2015-05-26

Review 5.  Limitations of routine neuroimaging in predicting outcomes of preterm infants.

Authors:  Hilary E A Whyte; Susan Blaser
Journal:  Neuroradiology       Date:  2013-08-18       Impact factor: 2.804

6.  Predictive values of cranial ultrasound and assessment of general movements for neurological development of preterm infants in the Maribor region of Slovenia.

Authors:  Polona Seme-Ciglenecki
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

7.  Comparing brain white matter on sequential cranial ultrasound and MRI in very preterm infants.

Authors:  Lara M Leijser; Lishya Liauw; Sylvia Veen; Inge P de Boer; Frans J Walther; Gerda van Wezel-Meijler
Journal:  Neuroradiology       Date:  2008-06-11       Impact factor: 2.804

8.  Development and Validation of a Dynamic Nomogram to Predict the Risk of Neonatal White Matter Damage.

Authors:  Wenjun Cao; Chenghan Luo; Mengyuan Lei; Min Shen; Wenqian Ding; Mengmeng Wang; Min Song; Jian Ge; Qian Zhang
Journal:  Front Hum Neurosci       Date:  2021-02-23       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.